Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
5,070.00
-90.00 (-1.74%)
Last updated: Aug 21, 2026, 3:00 PM KST
Kyongbo Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,922 | 7,228 | 4,128 | 4,477 | 6,348 | 4,290 |
Short-Term Investments | 520 | 820 | 2,000 | 870 | 870 | - |
Cash & Short-Term Investments | 13,828 | 8,048 | 6,128 | 5,347 | 7,218 | 4,290 |
Cash Growth | 214.21% | 31.34% | 14.60% | -25.92% | 68.25% | -79.55% |
Accounts Receivable | 70,755 | 63,268 | 51,624 | 56,160 | 50,202 | 46,906 |
Other Receivables | 507.62 | 1,392 | 686.7 | 697.94 | 597.63 | 988.69 |
Receivables | 71,263 | 64,660 | 52,311 | 56,858 | 50,799 | 47,895 |
Inventory | 76,560 | 80,977 | 90,585 | 70,664 | 57,443 | 57,670 |
Prepaid Expenses | 1,265 | 694.32 | 1,311 | 1,610 | 115.43 | 913.7 |
Other Current Assets | 6,984 | 4,758 | 1,606 | 1,423 | 749.74 | 397.53 |
Total Current Assets | 169,900 | 159,138 | 151,941 | 135,902 | 116,326 | 111,166 |
Property, Plant & Equipment | 164,648 | 128,023 | 99,852 | 96,073 | 93,919 | 95,677 |
Long-Term Investments | 9,538 | 10,202 | 11,121 | 13,676 | 11,935 | 14,384 |
Other Intangible Assets | 4,984 | 3,880 | 4,008 | 3,641 | 3,221 | 3,355 |
Long-Term Deferred Tax Assets | 12,682 | 13,587 | 13,565 | 13,203 | 11,951 | 10,179 |
Other Long-Term Assets | 5,815 | 4,708 | 3,399 | 3,810 | 3,194 | 2,218 |
Total Assets | 367,568 | 319,538 | 283,887 | 266,305 | 240,545 | 236,979 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 18,768 | 14,771 | 14,951 | 22,775 | 14,742 | 16,404 |
Accrued Expenses | 3,398 | 4,102 | 3,537 | 3,398 | 2,793 | 2,553 |
Short-Term Debt | 131,436 | 101,321 | 89,271 | 73,095 | 63,900 | 55,234 |
Current Portion of Long-Term Debt | - | - | 45 | 90 | 90 | 90 |
Current Portion of Leases | 929.6 | 1,010 | 1,074 | 1,078 | 280.59 | 787.02 |
Current Income Taxes Payable | 173.89 | - | 86.85 | 118.34 | 166.28 | - |
Other Current Liabilities | 38,840 | 26,045 | 23,695 | 17,707 | 13,596 | 13,746 |
Total Current Liabilities | 193,546 | 147,249 | 132,660 | 118,261 | 95,569 | 88,814 |
Long-Term Debt | 24,000 | 24,000 | - | 45 | 135 | 225 |
Long-Term Leases | 1,635 | 340.27 | 1,043 | 1,629 | 106.58 | 250.75 |
Pension & Post-Retirement Benefits | - | 114.83 | 1,482 | - | - | 927.43 |
Other Long-Term Liabilities | 1,396 | 2,096 | 2,548 | 1,988 | 1,030 | 1,061 |
Total Liabilities | 220,577 | 173,800 | 137,733 | 121,924 | 96,841 | 91,278 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 11,953 | 11,953 | 11,953 | 11,953 | 11,953 | 11,953 |
Additional Paid-In Capital | 40,067 | 40,067 | 40,067 | 40,067 | 40,067 | 40,067 |
Retained Earnings | 100,016 | 98,125 | 98,333 | 96,033 | 94,695 | 94,587 |
Comprehensive Income & Other | -5,046 | -4,408 | -4,199 | -3,672 | -3,012 | -907.41 |
Shareholders' Equity | 146,991 | 145,738 | 146,154 | 144,381 | 143,704 | 145,701 |
Total Liabilities & Equity | 367,568 | 319,538 | 283,887 | 266,305 | 240,545 | 236,979 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 158,001 | 126,671 | 91,433 | 75,936 | 64,512 | 56,587 |
Net Cash (Debt) | -144,173 | -118,623 | -85,305 | -70,589 | -57,294 | -52,296 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -6028.88 | -4961.88 | -3567.15 | -2952.68 | -2439.66 | -2190.88 |
Filing Date Shares Outstanding | 23.98 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Total Common Shares Outstanding | 23.98 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Working Capital | -23,646 | 11,889 | 19,281 | 17,641 | 20,757 | 22,352 |
Book Value Per Share | 6129.28 | 6096.06 | 6113.48 | 6039.33 | 6011.00 | 6094.52 |
Tangible Book Value | 142,006 | 141,858 | 142,146 | 140,741 | 140,483 | 142,346 |
Tangible Book Value Per Share | 5921.44 | 5933.76 | 5945.84 | 5887.05 | 5876.26 | 5954.19 |
Land | 35,051 | 30,146 | 30,146 | 28,633 | 27,569 | 23,874 |
Buildings | 102,331 | 92,725 | 82,779 | 81,336 | 79,341 | 76,851 |
Machinery | 141,623 | 136,978 | 125,238 | 119,358 | 113,325 | 111,022 |
Construction In Progress | 46,870 | 24,850 | 7,959 | 1,856 | 1,444 | 1,729 |